GLOBUS MEDICAL (GMED)

The company organizes its business around two main product categories. Musculoskeletal solutions make up the core of the portfolio and include implants, instruments, and related products used primarily in spine and orthopedic surgery. Enabling technologies include systems designed to improve surgical planning, navigation, imaging, and execution, reflecting the broader move in healthcare toward more precise, data-supported, and minimally disruptive procedures.

Globus Medical generates most of its revenue from musculoskeletal products, and the United States is its largest market, although the company also sells internationally. Its competitive position depends on innovation, surgeon relationships, clinical outcomes, regulatory compliance, and the ability to provide integrated solutions that meet the needs of operating rooms and care teams.

The company is distinctive because it combines a broad implant and instrument portfolio with technology intended to enhance surgical capability. In a market where hospitals seek efficiency and reproducible outcomes, Globus Medical’s strategy centers on expanding its product range, supporting surgeon adoption, and building platforms that can be used across procedure types. Its performance is closely tied to procedure volumes, hospital capital spending, reimbursement conditions, and demand for advanced orthopedic and spine solutions.